Skip to main content

Schistosomiasis Mansoni-Associated Kidney Disease

  • Chapter
  • First Online:
Tropical Nephrology

Abstract

Schistosomiasis is a tropical disease currently found in approximately 70 countries, mainly in Africa, the Eastern Mediterranean, and South America. An estimated 200 million people are infected. Schistosomiasis-associated kidney disease is not often described in the literature, and most studies show an association between the disease and glomerular alterations, especially in those patients with more severe clinical presentation. In this chapter, we review the general aspects of the disease and describe the characteristics of renal involvement in schistosomiasis mansoni. The disease is associated with high morbidity and mortality, and chronic complications are usually seen in individuals with high parasite burden, which usually occurs in those living in endemic areas. The clinical presentation of schistosomiasis results from the host’s immune response to Schistosoma eggs and the granulomatous reaction elicited by the antigens that they secrete. The immunological nature of the glomerular lesion is well established, and depends on the release of antigenic molecules produced by the parasite, triggering the formation of immune complexes that are deposited in the glomeruli. Although antigens from the adult worm are the most often related to schistosomal glomerulopathy, soluble egg antigens also contribute to the pathogenesis of glomerulopathy, as demonstrated in experimental studies. Glomerular injury is also related to the parasitosis intensity and the type and duration of the process. Membranoproliferative glomerulonephritis and focal and segmental glomerulosclerosis (FSGS) represent the patterns of glomerular injury most consistently associated with the hepatosplenic form of schistosomiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. AAF M. Esquistossomose. In: Bennett JC, Plum F, editors. Cecil: Tratado de Medicina Interna. 20th ed. Rio de Janeiro: Guanabara-Koogan; 1997. p. 2127–32.

    Google Scholar 

  2. Ross AGP, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med. 2002;346:1212–20.

    Article  PubMed  Google Scholar 

  3. Chitsulo L, Loverde P, Engels D. Disease watch: schistosomiasis. TDR Nat Rev Microbiol. 2004;2:12–3.

    Article  CAS  Google Scholar 

  4. Maguire JH. Trematodes (Schistosomes and Other Flukes). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s: principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 3595–605.

    Chapter  Google Scholar 

  5. Molyneu DH, Hotez PJ, Fenwick A. “Rapid-impact interventions”: how a policy of integrated control for Africa’s neglected tropical diseases could benefit the poor. PLoS Med. 2005;2:1064–70.

    Google Scholar 

  6. Vanderwerf MJ, De Valasl SJ, Brooker S, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 2003;86:125–39.

    Article  Google Scholar 

  7. Steinmann P, Keiser J, Bos R, et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6:411–25.

    Article  PubMed  Google Scholar 

  8. Passos ADC, Amaral RS. Esquistossomose mansônica: aspectos epidemiológicos e de controle. Rev Soc Bras Med Trop. 1998;31:61–74.

    PubMed  Google Scholar 

  9. Katz N, Peixoto SV. Análise crítica da estimativa do número de portadores de esquistossomose mansoni no Brasil. Rev Soc Bras Med Trop. 2000;33:303–8.

    Article  CAS  PubMed  Google Scholar 

  10. Resendes APC, Souza SR, Barbosa CS. Hospitalization and mortality from mansoni schistosomiasis in the State of Pernambuco, Brazil,1992/2000. Cad Saúde Pública. 2005;21:1392–401.

    Article  PubMed  Google Scholar 

  11. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica. 7th ed. Brasília, DF; 2010.

    Google Scholar 

  12. BRASIL. Ministério da Saúde. Sistema de informação de agravos de notificação/ Sistema de informação da esquistossomose. Casos confirmados de Esquistossomose: Brasil, Grandes Regiões e Unidades Federadas. 1995a 2011. Brasília; 2012. Available at:http://portal.saude.gov.br/portal/arquivos/pdf/serie_historica_esquistossomose_07_08_2012.pdf. Accessed 03 abr 2013.

  13. Ministério da Saúde. DATASUS. http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinan/pce/ cnv/pcebr.def. Accessed 25 Mar 2018.

  14. Blanchard TJ. Schistosomiasis. Travel Med Infect Dis. 2004;2:5–11.

    Article  PubMed  Google Scholar 

  15. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Doenças infecciosas e parasitárias: guia de bolso. 5. ed. ampl. Brasília; 2005a. Available at: www.saude.gov.br/svs. Accessed 8 Mar 2012.

  16. Martinelli R, Silveira MA, Rocha H. Glomerulonefrites associadas às doenças parasitárias. In: Barros RT, editor. Glomerulopatias: patogenia, clínica e tratamento. São Paulo: Sarvier; 2006. p. 352–71.

    Google Scholar 

  17. Domingues ALC, Novais S. Esquistossomose mansônica. In: Filgueira NA, editor. Condutas em clínica médica. Rio de Janeiro: Medsi; 2004. p. 659–69.

    Google Scholar 

  18. Coutinho HM, Acosta LP, Wu HW, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis. 2007;195:288–95.

    Google Scholar 

  19. Cheever AW, Hoffmann KF, Wynn TA. Immunopathology of schistosomiasis mansoni in mice and men. Immunol Today. 2000;21:465–6.

    Article  CAS  PubMed  Google Scholar 

  20. Corachan M. Schistosomiasis and international travel. Clin Infect Dis. 2002;35:446–50.

    Article  PubMed  Google Scholar 

  21. Mountford AP. Immunological aspects of schistosomiasis. Parasite Immunol. 2005;27:243–6.

    Article  CAS  PubMed  Google Scholar 

  22. Bina JC. Influência da terapêutica específica na evolução da esquistossomose mansoni. Rev Patol Trop. 1981;10:221–67.

    Google Scholar 

  23. Stephenson L. The impact of schistosomiasis on human nutrition. Parasitology. 1993;107:107–23.

    Article  Google Scholar 

  24. Lamyman MJ, Noble DJ, Narang S, Dehalvi N. Small bowel obstruction secondary to intestinal schistosomiasis. Trans R Soc Trop Med Hyg. 2006;100:885–7.

    Article  PubMed  Google Scholar 

  25. Domingues ALC, Domingues LAW. Forma intestinal, hepatointestinal e hepatoesplênica. In: Malta J, editor. Esquistossomose mansônica, vol. 5. Recife: Ed UFPE; 1994. p. 91–105.

    Google Scholar 

  26. Lambertucci JR, Serufo JC, Gerspacher-Lara R, et al. Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop. 2000;77:101–9.

    Google Scholar 

  27. Andrade ZA, Van Marck EAE. Schistosomal glomerular disease. Mem Inst Oswaldo Cruz. 1984;79:499–506.

    Article  CAS  PubMed  Google Scholar 

  28. Prata A. Esquistossomose mansoni. In: Veronesi R, Foccacia R, editors. Tratado de Infectologia. São Paulo: Atheneu; 1997. p. 1354–72.

    Google Scholar 

  29. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa de Controle da Esquistossomose. Brasília; 2006.

    Google Scholar 

  30. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Vigilância da Esquistossomose Mansoni: diretrizes técnicas/Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. 4th ed. Brasília: Ministério da Saúde; 2014. 144p: il.

    Google Scholar 

  31. Barsoum RS. Schistosomal glomerulopathies. Kidney Int. 1993;44:1–12.

    Article  CAS  PubMed  Google Scholar 

  32. Van Velthuysen MLF. Glomerulopathy associated with parasitic infections. ParasitToday. 1996;12:102–7.

    Google Scholar 

  33. Rodrigues VL, Otoni A, Voieta I, et al. Glomerulonephritis in schistosomiasis mansoni: a time to reappraise. Rev Soc Bras Med Trop. 2010;43:638–42.

    Article  PubMed  Google Scholar 

  34. Queiroz FP, Brito E, Martinelli R. Influence of regional factors in the distribution of the histologic patterns of glomerulopathies in the nephrotic syndrome. Nephron. 1975;14:466–70.

    Article  CAS  PubMed  Google Scholar 

  35. Dos Santos WLC, Sweet GMM, Azevêdo LG, et al. Current distribution pattern of biopsy-proven glomerular disease in Salvador, Brazil, 40 years after an initial assessment. Braz J Nephrol. 2017;39(4):376–83.

    Article  Google Scholar 

  36. Melo ME, Silveira MA, Martinelli R. Alterações renais nas doenças parasitárias: esquistossomose, leptospirose e malária. In: Barros E, editor. Nefrologia: rotinas, diagnóstico e tratamento. Porto Alegre: Artmed; 2006. p. 309–16.

    Google Scholar 

  37. Deelder AM, Kornelis D, Marck V, et al. Schistosoma mansoni: characterization of two circulating polysaccharide antigens and the immunological response to these antigens in the mouse, hamster, and human infection. Exp. Parasitology. 1980;50:16–32.

    Google Scholar 

  38. Van Marck EA, Deelder AM, Gigase PL. Effect of partial portal vein ligation on immune glomerular deposits in Schistosoma mansoni infected mice. Br J Exp Pathol. 1977;58:412–7.

    Google Scholar 

  39. De Water R, Van Marck EA, Fransen JA, et al. Schistosoma mansoni: ultrastructural localization of the circulating anodic antigen and the circulating cathodic antigen in the mouse kidney glomerulus. Am J Trop Med Hyg. 1988;38:118–24.

    Google Scholar 

  40. Barsoum RS. Schistosomal glomerulopathy: selection factors. Nephrol Dial Transplant. 1987;2:488–97.

    CAS  PubMed  Google Scholar 

  41. De Brito T, Carneiro CR, Nakhle MC, et al. Localization by immunoelectron microscopy of Schistosoma mansoni antigens in the glomerulus of the hamster (Mesocricetusauratus). Kidney Exp Nephrol. 1998;6:368–76.

    Google Scholar 

  42. Digeon M, Droz D, Noel LH, et al. The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis. Clin Exp Immunol. 1979;35:329–37.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Sobh M, Moustafa F, Ramzy R, et al. Schistosoma mansoni nephropathy in Syrian golden hamsters: effect of dose and duration of infection. Nephron. 1991;59:121–30.

    Google Scholar 

  44. Barsoum R. The changing face of schistosomal glomerulopathy. Kidney Int. 2004;66:2472–84.

    Article  PubMed  Google Scholar 

  45. Brito T. Schistosoma mansoni associated glomerulopathy. Rev Inst Med Trop. 1999;41:269–72.

    Article  CAS  Google Scholar 

  46. Nussenzveig I, De Brito T, Carneiro CR, et al. Human Schistosoma mansoni-associated glomerulopathy in Brazil. Nephrol Dial Transplant. 2002;17:4–7.

    Google Scholar 

  47. Abensur H, Nussenzveig I, Saldanha LB, et al. Nephrotic syndrome associated with hepatointestinal schistosomiasis. Rev Inst Med Trop Sao Paulo. 1992;34:273–6.

    Article  CAS  PubMed  Google Scholar 

  48. Dos Santos WLC, Sweet GMM, Bahiense-Oliveira M, et al. Schistosomal glomerulopathy and changes in the distribution of histological patterns of glomerular diseases in Bahia, Brazil. Mem Inst Oswaldo Cruz. 2011;106:901–4.

    Article  Google Scholar 

  49. Andrade ZA, Rocha H. Schistosomal glomerulopathy. Kidney Int. 1979;16:23–9.

    Article  CAS  PubMed  Google Scholar 

  50. Martinelli R, Rocha H. Revisão/Atualização em Nefrologia Clínica: Envolvimento glomerular na esquistossomose mansônica. J Bras Nefrol. 1996;18:279–82.

    Google Scholar 

  51. Silva Júnior GB, Duarte DB, Barros EJG, et al. Schistosomiasis-associated kidney disease: a review. Asian Pac J Trop Dis. 2013;3:79–84.

    Article  Google Scholar 

  52. Martinelli R, Brito E, Rocha H. Value of beta 1C/1A globulin serum levels as an early index of glomerular involvement in Schistosoma mansoni infection. Am J Trop Med Hyg. 1980;29:882–995.

    Article  CAS  PubMed  Google Scholar 

  53. Duarte DB, Vanderlei LA, Bispo RKV, et al. Renal function in Hepatosplenic schistosomiasis – an assessment of renal tubular disorders. PLoS One. 2014;9:1–15.

    Google Scholar 

  54. Sobh M, Moustafa F, El-Arbagy, et al. Nephropathy in asymptomatic patients with active Schistosoma mansoni infection. Inter Urol Nephr. 1990;22:37–43.

    Google Scholar 

  55. Hanemann ALP, Libório AB, Daher EF, et al. Monocyte chemotactic Protein-1 (MCP-1) in patients with chronic schistosomiasis mansoni: evidences of subclinical renal inflammation. PLoS One. 2013;8:1–5.

    Article  CAS  Google Scholar 

  56. Martinelli R, Noblat ACB, Brito E, et al. Schistosoma mansoni-induced mesangiocapillary glomerulonephrites: influence of therapy. Kidney Int. 1989;35:1227–33.

    Google Scholar 

  57. Lima Verde EM, Lima Verde FAA, Silva Júnior GB, et al. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil. J Nephrol. 2007;20:432–8.

    Google Scholar 

  58. Oliveira RA, Silva Júnior GB, Souza CJ, et al. Evaluation of renal function in leprosy: a study of 59 consecutive patients. Nephrol Dial Transplant. 2008;23:256–62.

    Article  PubMed  Google Scholar 

  59. Oliveira RA, Lima CG, Mota RMS, et al. Renal function evaluation in patients with American Cutaneous Leishmaniasis after specific treatment with pentavalent antimonial. BMC Nephrol. 2012;13:44–9.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, editor. The liver and portal hypertension. Philadelphia: Saunders; 1964. p. 50–64.

    Google Scholar 

  61. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.

    Article  CAS  PubMed  Google Scholar 

  62. Duarte DB, Vanderlei LA, Bispo RKV, et al. Acute kidney injury in schistosomiasis: a retrospective cohort of 60 patients in Brazil. J Parasitol. 2015;101:244–7.

    Article  PubMed  Google Scholar 

  63. Jiang Y, Beller DI, Frendl G, et al. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol. 1992;148:2423–8.

    CAS  PubMed  Google Scholar 

  64. Segerer S, Nelson PJ, Schlöndorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol. 2000;11:152–76.

    CAS  PubMed  Google Scholar 

  65. Gryseels B, Polman K, Clerinx J, et al. Human schistosomiasis. Lancet. 2006;368:1106–18.

    Article  PubMed  Google Scholar 

  66. Martinelli R, Pereira JLC, Brito E, et al. Clinical course of focal segmental glomerulosclerosis associated with hepatosplenic Schistosomiasis mansoni. Nephron. 1995;69:131–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

To Fabio Rocha, for his help in developing the figures used in the chapter.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Duarte, D.B., De Francesco Daher, E., Pinheiro, M.E., Oliveira, M.J.C. (2020). Schistosomiasis Mansoni-Associated Kidney Disease. In: Bezerra da Silva Junior, G., De Francesco Daher, E., Barros, E. (eds) Tropical Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-030-44500-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44500-3_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-44499-0

  • Online ISBN: 978-3-030-44500-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics